CONTEXT: Polycystic ovary syndrome (PCOS), the most common endocrinopathy of reproductive-aged women, is characterized by ovulatory dysfunction and hyperandrogenism. OBJECTIVE: The aim was to compare gene expression between endometrial samples of normal fertile controls and women with PCOS. DESIGN AND SETTING: We conducted a case control study at university teaching hospitals. PATIENTS: Normal fertile controls and women with PCOS participated in the study. INTERVENTIONS: Endometrial samples were obtained from normal fertile controls and from women with PCOS, either induced to ovulate with clomiphene citrate or from a modeled secretory phase using daily administration of progesterone. MAIN OUTCOME MEASURE: Total RNA was isolated from samples and processed for array hybridization with Affymetrix HG U133 Plus 2 arrays. Data were analyzed using GeneSpring GX11 and Ingenuity Pathways Analysis. Selected gene expression differences were validated using RT-PCR and/or immunohistochemistry in separately obtained PCOS and normal endometrium. RESULTS: ANOVA analysis revealed 5160 significantly different genes among the three conditions. Of these, 466 were differentially regulated between fertile controls and PCOS. Progesterone-regulated genes, including mitogen-inducible gene 6 (MIG6), leukemia inhibitory factor (LIF), GRB2-associated binding protein 1 (GAB1), S100P, and claudin-4 were significantly lower in PCOS endometrium; whereas cell proliferation genes, such as Anillin and cyclin B1, were up-regulated. CONCLUSIONS: Differences in gene expression provide evidence of progesterone resistance in midsecretory PCOS endometrium, independent of clomiphene citrate and corresponding to the observed phenotypes of hyperplasia, cancer, and poor reproductive outcomes in this group of women.
CONTEXT: Polycystic ovary syndrome (PCOS), the most common endocrinopathy of reproductive-aged women, is characterized by ovulatory dysfunction and hyperandrogenism. OBJECTIVE: The aim was to compare gene expression between endometrial samples of normal fertile controls and women with PCOS. DESIGN AND SETTING: We conducted a case control study at university teaching hospitals. PATIENTS: Normal fertile controls and women with PCOS participated in the study. INTERVENTIONS: Endometrial samples were obtained from normal fertile controls and from women with PCOS, either induced to ovulate with clomiphene citrate or from a modeled secretory phase using daily administration of progesterone. MAIN OUTCOME MEASURE: Total RNA was isolated from samples and processed for array hybridization with Affymetrix HG U133 Plus 2 arrays. Data were analyzed using GeneSpring GX11 and Ingenuity Pathways Analysis. Selected gene expression differences were validated using RT-PCR and/or immunohistochemistry in separately obtained PCOS and normal endometrium. RESULTS: ANOVA analysis revealed 5160 significantly different genes among the three conditions. Of these, 466 were differentially regulated between fertile controls and PCOS. Progesterone-regulated genes, including mitogen-inducible gene 6 (MIG6), leukemia inhibitory factor (LIF), GRB2-associated binding protein 1 (GAB1), S100P, and claudin-4 were significantly lower in PCOS endometrium; whereas cell proliferation genes, such as Anillin and cyclin B1, were up-regulated. CONCLUSIONS: Differences in gene expression provide evidence of progesterone resistance in midsecretory PCOS endometrium, independent of clomiphene citrate and corresponding to the observed phenotypes of hyperplasia, cancer, and poor reproductive outcomes in this group of women.
Authors: John D Storey; Jennifer Madeoy; Jeanna L Strout; Mark Wurfel; James Ronald; Joshua M Akey Journal: Am J Hum Genet Date: 2007-01-11 Impact factor: 11.025
Authors: Richard O Burney; Said Talbi; Amy E Hamilton; Kim Chi Vo; Mette Nyegaard; Camran R Nezhat; Bruce A Lessey; Linda C Giudice Journal: Endocrinology Date: 2007-05-17 Impact factor: 4.736
Authors: S Talbi; A E Hamilton; K C Vo; S Tulac; M T Overgaard; C Dosiou; N Le Shay; C N Nezhat; R Kempson; B A Lessey; N R Nayak; L C Giudice Journal: Endocrinology Date: 2005-11-23 Impact factor: 4.736
Authors: Xia Jiang; Jing Tan; Jingsong Li; Saul Kivimäe; Xiaojing Yang; Li Zhuang; Puay Leng Lee; Mark T W Chan; Lawrence W Stanton; Edison T Liu; Benjamin N R Cheyette; Qiang Yu Journal: Cancer Cell Date: 2008-06 Impact factor: 31.743
Authors: Jae-Wook Jeong; Hee Sun Lee; Kevin Y Lee; Lisa D White; Russell R Broaddus; Yu-Wen Zhang; George F Vande Woude; Linda C Giudice; Steven L Young; Bruce A Lessey; Sophia Y Tsai; John P Lydon; Francesco J DeMayo Journal: Proc Natl Acad Sci U S A Date: 2009-05-13 Impact factor: 11.205
Authors: T T Piltonen; J Chen; D W Erikson; T L B Spitzer; F Barragan; J T Rabban; H Huddleston; J C Irwin; L C Giudice Journal: J Clin Endocrinol Metab Date: 2013-07-03 Impact factor: 5.958
Authors: T T Piltonen; J C Chen; M Khatun; M Kangasniemi; A Liakka; T Spitzer; N Tran; H Huddleston; J C Irwin; L C Giudice Journal: Hum Reprod Date: 2015-03-06 Impact factor: 6.918